Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 378d-2 host gene (MIR378D2HG) is the host gene for the non-coding microRNA MIR378D2, also known as microRNA 378d-2. Like other microRNA host genes, MIR378D2HG itself does not encode a protein but serves as the genomic context from which the microRNA is transcribed. MicroRNAs (miRNAs) are short (20–24 nucleotide) non-coding RNAs that regulate gene expression post-transcriptionally, mainly by binding to target messenger RNAs (mRNAs) and inhibiting their translation or promoting their degradation[1]. There is no evidence indicating that MIR378D2HG is itself a therapeutic target, nor is it associated with enzyme, transporter, or receptor activity. Information about direct biological function or disease association specific to the MIR378D2 host gene is lacking, and the clinical roles attributed to “miR-378d-2” reflect microRNA rather than host gene biology[1]. The term is technically valid as a gene name, but its use as a therapeutic target or functional molecule is incorrect, so the entry is flagged as incorrect for a therapeutic target context. Explanation and context: - The main entry, “MIR378D2 host gene,” refers to the non-coding region of DNA from which the microRNA MIR378D2 is transcribed—not to a distinct functional protein or recognized therapeutic target class[1]. - The actual biological and disease roles ascribed to “miR-378d-2” or related microRNAs are not functions of the host gene per se, but of the mature microRNA itself, which may regulate numerous genes post-transcriptionally (in general, microRNAs can influence cell cycle, metabolism, apoptosis, and more; but these are not direct properties of their host genes)[2][3][4]. - No therapeutic drugs or mechanisms of action directly target microRNA host genes; existing research and interventions focus on the microRNAs themselves. - No established role as a biomarker or known safety concerns are attributed to MIR378D2HG. - MIR378D2HG is not recognized as a receptor, enzyme, transporter, or any standard molecular target class. Summary of issue: - “MIR378D2 host gene” is not a therapeutic target itself; it is a non-coding host locus for a microRNA. - If the query intends to retrieve information relevant to microRNA biology, focus should instead be placed on MIR378D2 (microRNA 378d-2). - There is no evidence that MIR378D2HG acts as a protein, drug target, or functional biological entity beyond its role in hosting MIR378D2[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 378d-2 host gene (MIR378D2HG).